Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Top Ranked Value Stocks To Buy For February 13th

Published 02/12/2019, 10:06 PM
Updated 07/09/2023, 06:31 AM

Here are four stocks with buy rank and strong value characteristics for investors to consider today, February 13th:

Jabil Inc. (JBL): This electronic manufacturing services and solutions provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1% over the last 60 days.

Jabil, Inc. Price and Consensus

Jabil, Inc. price-consensus-chart | Jabil, Inc. Quote

Jabil has a price-to-earnings ratio (P/E) of 9.34, compared with 17.90 for the industry. The company possesses a Value Score of B.

Jabil, Inc. PE Ratio (TTM)

Jabil, Inc. pe-ratio-ttm | Jabil, Inc. Quote

LexinFintech Holdings Ltd. (LX): This online consumer finance platform has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.

LexinFintech has a price-to-earnings ratio (P/E) of 7.09, compared with 8.40 for the industry. The company possesses a Value Score of B.

Ardagh Group S.A. (ARD): This rigid packaging solutions manufacturer for the food and beverage markets has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.

Ardagh has a price-to-earnings ratio (P/E) of 7.10, compared with 17.20 for the industry. The company possesses a Value Score of A.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

SkyWest, Inc. (SKYW): This regional airline has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 5.3% over the last 60 days.

SkyWest has a price-to-earnings ratio (P/E) of 9.48, compared with 14.20 for the industry. The company possesses a Value Scoreof A.

SkyWest, Inc. PE Ratio (TTM)

SkyWest, Inc. pe-ratio-ttm | SkyWest, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



LexinFintech Holdings Ltd. Sponsored ADR (LX): Free Stock Analysis Report

Jabil, Inc. (JBL): Free Stock Analysis Report

British American Tobacco (LON:BATS

Ardagh Group S.A. (ARD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.